Literature DB >> 17885290

PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status.

Delphine Sauce1, Jorge R Almeida, Martin Larsen, Laurine Haro, Brigitte Autran, Gordon J Freeman, Victor Appay.   

Abstract

OBJECTIVE AND
DESIGN: PD-1 expression on HIV-specific CD8 T cells was recently reported to reflect functional exhaustion, resulting in uncontrolled HIV-1 replication. Assessing PD-1 expression on T cells may be highly relevant in T-cell immunology and vaccine monitoring. However, this requires us to gain further insights into the significance of PD-1 expression on CD8 T cells in humans.
METHODS: We performed a detailed analysis of PD-1 expression pattern on various CD8 T cell subsets from healthy or HIV infected donors.
RESULTS: PD-1 expression has two facets in vivo. On the one hand, it is linked to T-cell differentiation: PD-1 is up-regulated on early/intermediate differentiated subsets, which include HIV and Epstein-Barr virus-specific CD8 T-cell populations, but is down-regulated during late stages of differentiation. On the other hand, it is linked to T-cell activation: on PD-1 positive cells, PD-1 over-expression occurs along with the up-regulation of activation markers such as CD38 or HLA-DR.
CONCLUSIONS: PD-1 expression on CD8 T cells, including those specific for HIV, can be related both to their differentiation stage and their activation status. It is important to consider these findings when assessing the expression of PD-1 on T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885290     DOI: 10.1097/QAD.0b013e3282eee548

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  81 in total

1.  Different in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses.

Authors:  Hirokazu Koizumi; Masao Hashimoto; Mamoru Fujiwara; Hayato Murakoshi; Takayuki Chikata; Mohamed Ali Borghan; Atsuko Hachiya; Yuka Kawashima; Hiroshi Takata; Takamasa Ueno; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

2.  Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation.

Authors:  B Dedeoglu; A E de Weerd; L Huang; A W Langerak; F J Dor; M Klepper; W Verschoor; D Reijerkerk; C C Baan; N H R Litjens; M G H Betjes
Journal:  Clin Exp Immunol       Date:  2017-02-28       Impact factor: 4.330

3.  Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques.

Authors:  Kehmia Titanji; Vijayakumar Velu; Lakshmi Chennareddi; Matam Vijay-Kumar; Andrew T Gewirtz; Gordon J Freeman; Rama R Amara
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

4.  Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease.

Authors:  Brent E Palmer; Douglas G Mack; Allison K Martin; May Gillespie; Margaret M Mroz; Lisa A Maier; Andrew P Fontenot
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

5.  Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors.

Authors:  Mathias Lichterfeld; Danlei Mou; Thai Duong Hong Cung; Katie L Williams; Michael T Waring; Jinghe Huang; Florencia Pereyra; Alicja Trocha; Gordon J Freeman; Eric S Rosenberg; Bruce D Walker; Xu G Yu
Journal:  Blood       Date:  2008-08-26       Impact factor: 22.113

6.  Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma.

Authors:  Yuki Honda; Atsushi Otsuka; Sachiko Ono; Yosuke Yamamoto; Judith A Seidel; Satoshi Morita; Masahiro Hirata; Tatsuki R Kataoka; Tatsuya Takenouchi; Kazuyasu Fujii; Takuro Kanekura; Yuko Okubo; Kenzo Takahashi; Teruki Yanagi; Daichi Hoshina; Hiroo Hata; Riichiro Abe; Taku Fujimura; Takeru Funakoshi; Koji Yoshino; Mamiko Masuzawa; Yasuyuki Amoh; Ryota Tanaka; Yasuhiro Fujisawa; Tetsuya Honda; Kenji Kabashima
Journal:  Oncoimmunology       Date:  2016-11-04       Impact factor: 8.110

Review 7.  CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Authors:  Marius Strioga; Vita Pasukoniene; Dainius Characiejus
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

8.  Responsiveness of HIV-specific CD4 T cells to PD-1 blockade.

Authors:  Filippos Porichis; Douglas S Kwon; Jennifer Zupkosky; Daniel P Tighe; Ashley McMullen; Mark A Brockman; David F Pavlik; Marta Rodriguez-Garcia; Florencia Pereyra; Gordon J Freeman; Daniel G Kavanagh; Daniel E Kaufmann
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

9.  Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection.

Authors:  Delphine Sauce; Martin Larsen; Rachel J M Abbott; Andrew D Hislop; Alison M Leese; Naeem Khan; Laura Papagno; Gordon J Freeman; Alan B Rickinson
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

10.  Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation.

Authors:  Bertram Bengsch; Bianca Seigel; Marianne Ruhl; Jörg Timm; Martin Kuntz; Hubert E Blum; Hanspeter Pircher; Robert Thimme
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.